$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Is there any generic version of Gilteritinib and its market price comparison?
2026-02-01 22:25:32
Check Details
How many years should pirfenidone (Isri) be used to treat pulmonary fibrosis and its course of treatment should be evaluated
2026-02-01 22:25:32
Check Details
Differences and medication options between canafenib/encofenib (bitavir) and vemurafenib
2026-02-01 22:25:32
Check Details
Which company produces Imatinib and an introduction to drug quality assurance
2026-02-01 22:25:32
Check Details
Ruxolitinib Cream (Opzelura) Manufacturer and Drug Quality Assurance Information
2026-02-01 22:25:32
Check Details
Analysis of how many months and treatment courses it usually takes to cure hepatitis C with Epclusa
2026-02-01 22:25:32
Check Details
Introduction to the price and purchase channels of foreign generic drugs of Sunitinib
2026-02-01 22:25:32
Check Details
How to safely discontinue tazetostat (Daveco) and the precautions for discontinuation
2026-02-01 22:25:32
Check Details
Common side effects of ceritinib/ceritinib (Zanda) and safe medication management methods
2026-02-01 22:25:32
Check Details
Actual out-of-pocket amount and cost reference for Belzutifan after medical insurance reimbursement
2026-02-01 22:25:32
Check Details
Whether dabrafenib (Tefila) needs to be taken for life and suggestions on treatment course adjustment
2026-02-01 22:25:32
Check Details
Axitinib (Inlida) official detailed instructions and full analysis of precautions for use
2026-02-01 22:25:32
Check Details
1
2
...
2051
2052
2053
2054
2055
2056
2057
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma